Differences in the predominance of lysosomal and autophagic pathologies between infants and adults with Pompe

Nina Raben1, Evelyn Ralston, Yin-Hsiu Chien

  • 1Arthritis and Rheumatism Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892-1820, USA. rabenn@mail.nih.gov

Insights

Infants with Pompe disease show expanded lysosomes, not autophagy, unlike adults. Enzyme replacement therapy unmasks autophagy by clearing glycogen, suggesting different infant and adult Pompe disease pathogenesis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Genetics

Background:

  • Pompe disease is a lysosomal storage disorder due to acid alpha-glucosidase deficiency, impacting glycogen degradation.
  • Infantile Pompe disease presents with severe cardiomyopathy and myopathy; late-onset forms primarily affect skeletal muscle.
  • Autophagic inclusions are prominent in adult Pompe disease patients and mouse models.

Purpose of the Study:

  • To evaluate the autophagic pathology in infants with Pompe disease before and after enzyme replacement therapy (ERT).
  • To investigate the role of autophagy in infantile Pompe disease pathogenesis.
  • To compare infantile Pompe disease pathology with that observed in adult patients.

Main Methods:

  • Analysis of single muscle fibers from biopsies of infants before and 6 months after ERT.
  • Staining for autophagosomal and lysosomal markers, followed by confocal microscopy.
  • Second harmonic imaging of unstained muscle bundles.

Main Results:

  • Infants displayed significantly expanded lysosomes, with negligible autophagic components, contrary to adult patients.
  • Following 6 months of ERT, autophagic buildup became apparent after glycogen clearance.
  • The two pathologies (expanded lysosomes and autophagy) did not appear to coexist in most muscle fibers.

Conclusions:

  • Infantile Pompe disease pathogenesis differs from adult forms, characterized initially by lysosomal expansion rather than autophagy.
  • Enzyme replacement therapy may reveal underlying autophagic pathology by clearing accumulated glycogen.
  • These findings highlight distinct pathological mechanisms in infantile versus adult Pompe disease.

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...